InnovAge Holding Corp. (INNV) stock
INNVNasdaqServices-Health ServicesFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3064% above fair value
$9.47+0.07 (+0.74%)
Close on Nov 13, 2026Market cap $1.29BP/E –Yield –
InnovAge EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
InnovAge's EPS for the twelve months ending Jun 30, 2026 was -$0.02. For fiscal 2026 it was -$0.02. The highest annual figure on record is $0.19 in fiscal 2020.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -$0.02 | – |
| FY2025 | Jun 30, 2025 | -$0.22 | – |
| FY2024 | Jun 30, 2024 | -$0.16 | – |
| FY2023 | Jun 30, 2023 | -$0.30 | – |
| FY2022 | Jun 30, 2022 | -$0.05 | – |
| FY2021 | Jun 30, 2021 | -$0.36 | -289.5% |
| FY2020 | Jun 30, 2020 | $0.19 | – |
Quarterly eps
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $0.06 | – |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | -$0.22 | – |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $0.08 | – |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $0.06 | – |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | -$0.01 | – |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | -$0.08 | – |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | -$0.10 | – |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | -$0.04 | – |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | -$0.01 | – |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | -$0.04 | – |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | -$0.03 | – |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | -$0.08 | – |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | -$0.08 | – |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | -$0.05 | – |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | -$0.07 | -800.0% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | -$0.10 | -266.7% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | -$0.09 | -280.0% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | -$0.02 | – |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $0.01 | -87.5% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $0.06 | – |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $0.05 | -44.4% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | -$0.09 | -250.0% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $0.08 | – |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | -$0.41 | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $0.09 | – |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $0.06 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?